Publication | Closed Access

Retro-inverso bradykinin opens the door of blood–brain tumor barrier for nanocarriers in glioma treatment

NanomedicineNeuro-oncologyDrug TargetingNanotherapeuticsTherapeutic NanomaterialsBlood–brain Tumor BarrierMedicineGlioma TreatmentNano-drug DeliveryTumor TargetingRadiation OncologyPharmacologyGliomaRetro-inverso Bradykinin